AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...

The legal proceedings involved stopped Ironmouse from explaining how the talent agency and production company owed her money ...

In response to the overwhelming generosity shown, the Immune Deficiency Foundation's president & CEO, Jorey Berry, thanked Ironmouse for her efforts. The organization released a video on its official ...

Revised Phase 2 Strategy Targets Event-Free Survival in Primary Head and Neck Cancer through Checkpoint Inhibitor Combination ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...

Findings published in JAMA Dermatology suggest that the use of immune checkpoint inhibitors may double psoriasis risk for ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Blindness, pneumonia, severe diarrhoea and even death – measles virus infections, especially in children, can have ...

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and ...